Perspective Therapeutics (CATX) Long-Term Investments (2012 - 2023)

Perspective Therapeutics has disclosed Long-Term Investments across 12 years of filings, most recently posting $2.2 million for Q3 2023.

• In Q3 2023, Long-Term Investments fell 1.5% year-over-year to $2.2 million; the TTM figure through Sep 2023 stood at $2.2 million (down 1.5% YoY), while the FY2022 annual figure was $2.4 million, changed N/A from the prior year.
• Long-Term Investments came in at $2.2 million for Q3 2023 at Perspective Therapeutics, down from $2.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $2.4 million in Q4 2022 to a low of $76000.0 in Q2 2021.
• Average Long-Term Investments over 5 years is $919842.1, with a median of $243000.0 recorded in 2019.
• Year-over-year, Long-Term Investments plunged 54.11% in 2019 and soared 2969.74% in 2022.
• Over 5 years, Long-Term Investments stood at $127000.0 in 2019, then soared by 59.06% to $202000.0 in 2020, then soared by 266.83% to $741000.0 in 2021, then surged by 223.35% to $2.4 million in 2022, then decreased by 6.64% to $2.2 million in 2023.
• Per Business Quant data, the three most recent Long-Term Investments figures were $2.2 million in Q3 2023, $2.3 million in Q2 2023, and $2.3 million in Q1 2023.